Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors - International Journal of Radiation Oncology, Biology, Physics
Mechanism of action of gefitinib. EGF = epidermal growth factor; EGFR =... | Download Scientific Diagram
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
Clinical development of targeted and immune based anti-cancer therapies | Journal of Experimental & Clinical Cancer Research | Full Text
Gefitinib - an overview | ScienceDirect Topics
Enoxaparin Sensitizes Human Non–Small-Cell Lung Carcinomas to Gefitinib by Inhibiting DOCK1 Expression, Vimentin Phosphorylation, and Akt Activation | Molecular Pharmacology
Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer | Oncotarget
Mechanisms of cancer resistance to Gefitinib (Iressa). (a) HER1... | Download Scientific Diagram
Plausible mechanisms of action of miRNAs in the restoration of... | Download Scientific Diagram
Anti-EGFR Mechanism of Action: Antitumor Effect and Underlying Cause of Adverse Events
Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro - ScienceDirect
Epidermal growth factor receptor inhibition strategies in oncology in: Endocrine-Related Cancer Volume 11 Issue 4 (2004)
Anti‐tumor activity of WK88‐1, a novel geldanamycin derivative, in gefitinib‐resistant non‐small cell lung cancers with Met amplification - Jang - 2014 - Cancer Science - Wiley Online Library
Epithelial membrane protein-1 is a biomarker of gefitinib resistance | PNAS
EGFR pathway and mechanism of action of osimertinib. Abbreviation:... | Download Scientific Diagram
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer | European Respiratory Society
Frontiers | EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies | Oncology
Mechanisms of action of EGFR inhibitors | EGFR Inhibitors in Cancer Treatment
Afatinib mechanism of action. Notes: From Hirsh, 45 with permission.... | Download Scientific Diagram
Dacoplice® | Pfizer India | Mechanism of action
Development of treatment options for Chinese patients with advanced sq | OTT
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway - ScienceDirect
IJMS | Free Full-Text | Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer | HTML
Frontiers | Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study | Oncology
Gefitinib — a novel targeted approach to treating cancer | Nature Reviews Cancer
EGFR pathway and mechanism of action of osimertinib. Abbreviation:... | Download Scientific Diagram
Action mechanism of epidermal growth factor receptor-tyrosine kinase... | Download Scientific Diagram
![PDF] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8a326536a82985b639a71a821682a23fc08747e9/2-Figure1-1.png "PDF] Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence. | Semantic Scholar")